CFMC
ABBV icon

Curbstone Financial Management Corp’s AbbVie ABBV Stock Holding History

Curbstone Financial Management Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12M Buy
12,403
+1,822
+17% +$392K 0.53% 45
2026
Q1 		$2.3M Sell
10,581
-186
-2% -$41.3K 0.44% 56
2025
Q4 		$2.46M Sell
10,767
-300
-3% -$68.3K 0.47% 50
2025
Q3 		$2.56M Sell
11,067
-150
-1% -$30.5K 0.49% 49
2025
Q2 		$2.08M Sell
11,217
-1,715
-13% -$319K 0.43% 59
2025
Q1 		$2.71M Buy
12,932
+2,233
+21% +$434K 0.57% 46
2024
Q4 		$1.9M Buy
10,699
+156
+1% +$28.7K 0.4% 60
2024
Q3 		$2.08M Sell
10,543
-378
-3% -$70.5K 0.45% 54
2024
Q2 		$1.87M Sell
10,921
-394
-3% -$65.3K 0.41% 62
2024
Q1 		$2.06M Sell
11,315
-150
-1% -$25.9K 0.45% 59
2023
Q4 		$1.78M Buy
11,465
+100
+0.9% +$14.6K 0.4% 65
2023
Q3 		$1.69M Sell
11,365
-200
-2% -$29.4K 0.42% 65
2023
Q2 		$1.56M Sell
11,565
-250
-2% -$36.7K 0.37% 72
2023
Q1 		$1.88M Sell
11,815
-200
-2% -$30.6K 0.46% 62
2022
Q4 		$1.94M Sell
12,015
-3,150
-21% -$483K 0.49% 58
2022
Q3 		$2.04M Sell
15,165
-24
-0.2% -$3.44K 0.51% 53
2022
Q2 		$2.33M Sell
15,189
-2,618
-15% -$400K 0.54% 54
2022
Q1 		$2.89M Buy
17,807
+150
+0.8% +$21.8K 0.53% 52
2021
Q4 		$2.39M Buy
17,657
+90
+0.5% +$10.6K 0.42% 64
2021
Q3 		$1.9M Buy
17,567
+304
+2% +$34.7K 0.36% 71
2021
Q2 		$1.94M Buy
17,263
+100
+0.6% +$11.3K 0.37% 71
2021
Q1 		$1.86M Sell
17,163
-250
-1% -$26.7K 0.37% 70
2020
Q4 		$1.87M Buy
17,413
+350
+2% +$33.6K 0.39% 68
2020
Q3 		$1.5M Sell
17,063
-304
-2% -$28.6K 0.36% 72
2020
Q2 		$1.71M Sell
17,367
-550
-3% -$48.4K 0.44% 58
2020
Q1 		$1.36M Sell
17,917
-750
-4% -$63.9K 0.41% 62
2019
Q4 		$1.65M Hold
18,667
– – 0.39% 71
2019
Q3 		$1.41M Buy
18,667
+200
+1% +$13.7K 0.36% 73
2019
Q2 		$1.34M Sell
18,467
-480
-3% -$37.7K 0.35% 78
2019
Q1 		$1.53M Buy
18,947
+1,615
+9% +$132K 0.42% 64
2018
Q4 		$1.6M Hold
17,332
– – 0.48% 60
2018
Q3 		$1.64M Sell
17,332
-220
-1% -$20.9K 0.43% 63
2018
Q2 		$1.63M Sell
17,552
-150
-0.8% -$14.6K 0.45% 65
2018
Q1 		$1.68M Buy
17,702
+8,223
+87% +$903K 0.47% 59
2017
Q4 		$917K Sell
9,479
-10,583
-53% -$997K 0.51% 58
2017
Q3 		$1.78M Buy
20,062
+9,681
+93% +$737K 0.52% 63
2017
Q2 		$753K Buy
10,381
+150
+1% +$10.1K 0.45% 67
2017
Q1 		$667K Buy
10,231
+295
+3% +$18.5K 0.41% 71
2016
Q4 		$622K Sell
9,936
-9,936
-50% -$606K 0.39% 72
2016
Q3 		$1.25M Buy
19,872
+200
+1% +$12.9K 0.4% 73
2016
Q2 		$1.22M Sell
19,672
-1,100
-5% -$67K 0.41% 75
2016
Q1 		$1.19M Buy
20,772
+1,200
+6% +$66.9K 0.4% 70
2015
Q4 		$1.16M Buy
19,572
+9,936
+103% +$572K 0.4% 77
2015
Q3 		$524K Sell
9,636
-200
-2% -$13K 0.38% 79
2015
Q2 		$661K Sell
9,836
-375
-4% -$24.5K 0.44% 65
2015
Q1 		$598K Buy
10,211
+725
+8% +$43.8K 0.4% 70
2014
Q4 		$621K Buy
9,486
+80
+0.9% +$5.04K 0.48% 61
2014
Q3 		$543K Buy
9,406
+200
+2% +$11.1K 0.43% 66
2014
Q2 		$520K Sell
9,206
-250
-3% -$13.1K 0.4% 71
2014
Q1 		$486K Buy
+9,456
New +$478K 0.4% 73

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Curbstone Financial Management Corp's ABBV Position: Q2 2026 in Review

Curbstone Financial Management Corp increased its AbbVie (ABBV) stake by 17% in Q2 2026, buying an estimated $392K and bringing the position to 12,403 shares worth $3.12M. The position accounts for 0.53% of the portfolio, ranked #45.

Curbstone Financial Management Corp first reported a position in ABBV in Q1 2014 and has held it in 50 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Curbstone Financial Management Corp held 12,403 shares of AbbVie worth $3.12M as of Q2 2026.
  • Curbstone Financial Management Corp bought 1,822 AbbVie shares in Q2 2026, an estimated $392K.
  • AbbVie made up 0.53% of Curbstone Financial Management Corp's portfolio in Q2 2026, its #45 holding.
  • Curbstone Financial Management Corp first reported a position in AbbVie in Q1 2014 and has held it in 50 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Curbstone Financial Management Corp's 13F filing for Q2 2026, filed 14 Jul 2026.